FIELD: organic chemistry, heterocyclic compounds, pharmacy.
SUBSTANCE: invention relates to new derivatives of nitrogen-containing heterocyclic compounds of the general formula: (I) 
wherein X1-X5 mean CH2, or one of that means NH and another X1-X5 mean CH2; k = 0 or 1; R1 means (C1-C8)-alkyl, (C1-C8)-hydroxyalkoxy-group; t = 0, 1 or 2; A means phenyl or pyridinyl; R2 means hydrogen atom, hydroxyl group, halogen atom or (C1-C6)-alkyl, (C1-C6)-alkoxy-group; n = 0, 1-4; p = 0 or a whole number from 1 to 5; Y means -C(O)-; Z means CH2. Invention relates to their pharmaceutical acceptable salts also. Compounds of the formula (I) elicit agonistic activity with respect to muscarinic receptors and can be used in medicine.
EFFECT: valuable medicinal properties of compounds.
21 cl, 1 tbl, 17 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DERIVATIVES OF NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL AGENTS BASED ON THEREOF | 1999 |
|
RU2278111C2 |
| MUSCARINIC AGONISTS | 2001 |
|
RU2269523C2 |
| DERIVATIVES OF BENZIMIDAZOLIDINONE AS AGENTS FOR MUSCARINIC RECEPTORS | 2002 |
|
RU2288919C2 |
| MUSCARINIC RECEPTOR AGONISTS | 2015 |
|
RU2678835C2 |
| HETEROCYCLIC MUSCARINIC AGONISTS AND COMPOSITIONS, THEIR USING AND METHODS FOR TREATMENT | 2002 |
|
RU2292346C2 |
| BICYCLIC HETEROCYCLIC SPIROCOMPOUNDS | 2010 |
|
RU2506266C2 |
| DIAMIDE COMPOUNDS HAVING ACTIVITY OF MUSCARINIC RECEPTOR ANTAGONIST AND ACTIVITY OF β ADRENERGIC RECEPTOR AGONIST | 2010 |
|
RU2676686C2 |
| DIAMIDE COMPOUNDS POSSESSING MUSCARINIC ANTAGONIST ACTIVITY AND B2 ADRENERGIC RECEPTOR B2 AGONIST ACTIVITY | 2010 |
|
RU2543716C2 |
| AZACYCLIC COMPOUNDS TO BE USED IN TREATING SEROTONIN-MEDIATED DISEASES | 2001 |
|
RU2398765C1 |
| GUANIDINE-CONTAINING COMPOUNDS APPLICABLE AS MUSCARINIC RECEPTOR ANTAGONISTS | 2008 |
|
RU2480458C2 |
